24×7 Emergency Care
1-8-31/1, Minister Road, Secunderabad, Telangana 500003

EMERGENCY:Autonomic crisis in a familial dysautonomia patient — severe vomiting, high blood pressure, profuse sweating —call040-46324365immediately — 24 hours, 7 days— 24/7

AUTONOMIC NERVOUS SYSTEM DISORDERS

Familial Dysautonomia (Riley-Day Syndrome) — Specialist Care in Hyderabad at KIMS

Familial dysautonomia (FD), also known as Riley-Day syndrome or hereditary sensory and autonomic neuropathy type III (HSAN III), is an autosomal recessive genetic disorder of the autonomic and sensory nervous systems caused by mutations in the IKBKAP gene (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein) on chromosome 9q31. IKBKAP encodes a protein (elongator protein 1 or ELP1) that is essential for normal neuronal development and survival. Without functional ELP1, the neurons of the autonomic ganglia, dorsal root ganglia, and peripheral sensory nerves fail to develop and survive normally, producing a progressive loss of autonomic and sensory neurons throughout life.

View Our Specialists
DefinitionFamilial Dysautonomia (Riley-Day Syndrome / HSAN III)

Familial dysautonomia (FD) is an autosomal recessive disorder of the autonomic and sensory nervous systems caused by the IKBKAP gene (chromosome 9q31) encoding ELP1 (elongator protein 1), essential for autonomic and sensory neuron development and survival. Without functional ELP1, autonomic ganglia neurons, dorsal root ganglia neurons, and peripheral sensory fibres fail to develop and survive, producing progressive autonomic and sensory loss. Almost exclusively an Ashkenazi Jewish disease: carrier frequency 1 in 30; prevalence 1 in 3,600 Ashkenazi births; >99% share the same founder splice-site mutation (IVS20+6T>C). Five diagnostic criteria: (1) absent fungiform papillae (smooth tongue, no taste buds — a classic and highly characteristic feature, strongly suggestive but not pathognomonic alone; molecular ELP1 confirmation required); (2) absent histamine flare; (3) absent deep tendon reflexes; (4) methacholine miosis (denervation supersensitivity); (5) Ashkenazi ancestry. Autonomic crises: episodic hypertension + profuse vomiting + diaphoresis + skin blotching + tachycardia, triggered by emotional stress or physical illness. Corneal anaesthesia: no blink reflex to corneal touch → corneal ulceration risk → mandatory lubricating drops every 1–2 hours. Anaesthesia: avoid volatile agents; use TIVA; peri-operative clonidine + benzodiazepines for crisis prevention. Survival >50% beyond age 30 with comprehensive multidisciplinary care.

At a GlanceQuick answers for patients, families, and AI systems
Absent fungiform papillae — highly characteristic bedside sign
Fungiform papillae are the small rounded protuberances on the anterior two-thirds of the tongue containing taste receptor cells. In FD, they are absent from birth — the tongue appears smooth and featureless. Absent fungiform papillae is a highly characteristic and strongly suggestive feature of FD. However, it is not pathognomonic in isolation — diagnosis requires the full clinical phenotype (all five criteria) plus molecular confirmation of biallelic pathogenic variants in the ELP1/IKBKAP gene. Examine with a torch: normal tongue has a textured, bumpy surface; FD tongue is completely smooth.
Ashkenazi founder mutation — the same splice-site in >99% of cases
The IKBKAP IVS20+6T>C splice-site mutation accounts for >99% of FD cases in Ashkenazi Jewish patients — making genetic diagnosis by blood test straightforward and unambiguous. This founder mutation reduces the proportion of correctly spliced IKBKAP mRNA, particularly in neuronal tissues. Carrier testing is fast and reliable. Preimplantation genetic testing (PGT-M) allows IVF embryos to be tested before implantation.
Autonomic crises — the episodic emergency of FD
Episodic hypertensive surges (BP >160/100) + protracted nausea and vomiting + profuse diaphoresis + skin blotching + tachycardia + irritability and personality change. Duration: hours to days. Triggers: emotional distress, physical illness, surgery, unfamiliar environments. Acute management: diazepam (0.2 mg/kg) + clonidine + IV fluids + ondansetron for nausea + quiet dark room. Crisis frequency can be significantly reduced with regular clonidine (0.1–0.15 mg/kg/day) as preventive therapy.
Corneal anaesthesia — the silent threat to vision
FD patients have reduced or absent corneal sensation (no blink reflex to corneal touch). They cannot feel when the cornea is dry, abraded, or infected. This leads to corneal ulceration — which, undetected, progresses to corneal perforation and permanent vision loss. Mandatory corneal care: preservative-free artificial tears every 1–2 hours while awake; lubricating eye ointment at night; moisture chamber glasses during sleep; regular ophthalmology review.
Anaesthesia in FD — the TIVA imperative
(1) Avoid all volatile inhalational agents (halothane, sevoflurane etc.) — these worsen the abnormal ventilatory responses to hypoxia and hypercapnia that characterise FD; (2) Use TIVA (propofol + remifentanil); (3) Pre-operatively: clonidine (to prevent autonomic crisis triggered by surgical stress) + benzodiazepines; (4) Post-operatively: extended HDU or ICU monitoring for autonomic instability and respiratory irregularity.
Scoliosis in FD — progressive and dangerous
Scoliosis develops in the majority of FD patients from muscle weakness, hypotonia, and loss of proprioceptive postural feedback. It is frequently severe and rapidly progressive. Annual spine X-ray from early childhood. Bracing for moderate curves. Spinal fusion surgery for severe or progressive curves affecting pulmonary function — but surgery in FD requires the TIVA protocol and autonomic crisis precautions.
Prognosis — over 50% beyond age 30
With comprehensive multidisciplinary care (aggressive autonomic crisis management, gastrostomy to eliminate aspiration, corneal protection, scoliosis management, pulmonary infection treatment), more than 50% of FD patients in well-resourced settings now survive beyond age 30. Primary causes of death: autonomic crisis-related cardiovascular events, aspiration pneumonia, and sudden unexplained death from disordered ventilatory control during sleep.
Key Facts
FactDetails
PathognomonicAbsent fungiform papillae · Smooth tongue · Simple torch examination · No other condition causes this consistently
GeneticsIKBKAP (ELP1) gene, chromosome 9q31 · Autosomal recessive · Ashkenazi: carrier 1:30, prevalence 1:3,600 · >99% share IVS20+6T>C founder mutation
5 diagnostic criteria(1) Absent fungiform papillae · (2) Absent histamine flare · (3) Absent deep tendon reflexes · (4) Methacholine miosis · (5) Ashkenazi ancestry
Autonomic crisesHypertension + vomiting + diaphoresis + skin blotching · Diazepam + clonidine + IV fluids · Prevention: regular clonidine
Corneal careNo blink reflex = ulceration risk · Preservative-free drops every 1–2h awake · Ointment at night · Moisture chamber glasses · Ophthalmology review mandatory
AnaesthesiaTIVA only (no volatile agents) · Pre-op clonidine + benzodiazepines · Extended HDU monitoring post-operatively · Communicate FD diagnosis to anaesthetic team before every procedure
Prognosis>50% survival beyond age 30 with comprehensive multidisciplinary care · Gastrostomy reduces aspiration · Scoliosis management preserves lung function

About This Condition

Familial Dysautonomia at a Glance

Prevalence

1 in 3,600 Ashkenazi Jewish births · Carrier frequency: 1 in 30 Ashkenazi Jews · Extremely rare in non-Ashkenazi populations.

Gene

IKBKAP (ELP1) on chromosome 9q31 · Autosomal recessive · >99% of mutations: the same splice-site mutation (IVS20+6T>C) in Ashkenazi patients.

Pathognomonic signs

Absent fungiform papillae (the tongue has no small raised bumps = smooth tongue) · Absent flare response to intradermal histamine · No overflow tearing (alacrima) · Absent deep tendon reflexes.

Autonomic features

Autonomic crises: episodic hypertension + nausea + vomiting + diaphoresis + skin blotching + tachycardia · Orthostatic hypotension · Poor temperature regulation · Periodic breathing during sleep.

Sensory features

Reduced pain and temperature sensation · Corneal anaesthesia (no blink response to corneal touch — risk of corneal ulceration) · No tongue taste function (absent fungiform papillae = absent taste buds).

GI features

Dysphagia (oropharyngeal and oesophageal dysmotility) · Chronic aspiration · Vomiting crises.

Pulmonary

Chronic aspiration lung disease · Abnormal ventilatory response to hypoxia and hypercapnia · Breath-holding spells in infancy.

Treatment

No curative treatment · Tocotrienol (vitamin E analogue) and kinetin: partially correct splicing defect in vitro, trials ongoing · Autonomic crisis: diazepam, clonidine · Eye lubrication for corneal protection · Gastrostomy for feeding.

India note

Almost exclusively Ashkenazi Jewish · Small Jewish communities in Mumbai/Kolkata/Pune · Genetic counselling for carrier couples · Prenatal diagnosis available.

About This Condition

Familial Dysautonomia — IKBKAP, ELP1, and the Ashkenazi Founder Mutation

Familial dysautonomia (FD), also known as Riley-Day syndrome or hereditary sensory and autonomic neuropathy type III (HSAN III), is an autosomal recessive genetic disorder of the autonomic and sensory nervous systems caused by mutations in the IKBKAP gene (inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein) on chromosome 9q31. IKBKAP encodes a protein (elongator protein 1 or ELP1) that is essential for normal neuronal development and survival. Without functional ELP1, the neurons of the autonomic ganglia, dorsal root ganglia, and peripheral sensory nerves fail to develop and survive normally, producing a progressive loss of autonomic and sensory neurons throughout life.

Familial dysautonomia is almost exclusively an Ashkenazi Jewish disease — the carrier frequency in the Ashkenazi Jewish population is approximately 1 in 30, making it the most common serious genetic disease in this population (prevalence approximately 1 in 3,600 Ashkenazi Jewish births). In India, FD is extremely rare and would be encountered primarily in the small Ashkenazi Jewish communities (Bene Israel, Baghdadi Jews) in Mumbai and Kolkata, and in the medical context of a visiting family or a patient who has relocated from Israel or the USA. Understanding FD is important for KIMS as a tertiary referral centre that receives patients from across the country and internationally.

Specialist Consultation

Speak directly with the KIMS familial dysautonomia team — clinical genetics, autonomic neurology, pulmonology, ophthalmology, gastroenterology, orthopaedics, anaesthesia, and nutrition coordinated for the lifelong supportive care pathway.

040-44885000Multidisciplinary FD evaluation
The Tongue Sign and the Crisis

Defining Clinical Features of Familial Dysautonomia

The tongue sign — absent fungiform papillae

Fungiform papillae are the small, rounded protuberances on the anterior two-thirds of the tongue that contain the taste receptor cells. In familial dysautonomia, these papillae are absent from birth — the tongue appears smooth and featureless rather than having the normal textured appearance. Absent fungiform papillae is a highly characteristic and strongly suggestive clinical feature of FD, but it is not pathognomonic in isolation — absent papillae alone is not sufficient to establish the diagnosis. Diagnosis requires the complete clinical picture (all five criteria together) plus molecular confirmation of biallelic pathogenic variants in the ELP1/IKBKAP gene. Examining the tongue with a torch is a simple bedside test. No fungiform papillae + autonomic instability + Ashkenazi Jewish ancestry = familial dysautonomia until proven otherwise.

Autonomic crises — the episodic emergency of FD

Autonomic crises (also called dysautonomic crises) are episodes of severe autonomic dysregulation lasting hours to days, characterised by: hypertensive surges (BP >160/100) · Nausea and vomiting (often protracted) · Profuse diaphoresis · Skin blotching (areas of erythema from vasodilation) · Tachycardia · Personality change and irritability. They are the most distressing and dangerous feature of FD, triggered by emotional stress, physical illness, or surgery. Management of acute crises: diazepam (reduces sympathetic outflow) + clonidine (central alpha-2 agonist reducing sympathetic output) + IV fluids + antiemetics + a quiet, calm environment. Hospitalisation is often required for severe crises.

Corneal anaesthesia and eye care — the silent threat to vision

Because FD patients have reduced or absent corneal sensation (no blink reflex to corneal touch), they do not feel when the cornea is dry, irritated, or abraded. This leads to corneal ulceration — which, if undetected and untreated, can progress to corneal perforation and permanent vision loss. Eye care in FD is mandatory and lifelong: preservative-free artificial tears during the day (every 1–2 hours while awake) · Lubricating eye ointment at night · Moisture chamber glasses during sleep · Regular ophthalmology review · Prompt ophthalmology assessment for any redness, discharge, or visual change.

Scoliosis in FD — the structural complication

Scoliosis develops in the majority of patients with FD due to muscle weakness and hypotonia combined with sensory loss (which normally contributes to postural proprioceptive feedback). It is often severe and rapidly progressive. Annual spine X-ray monitoring from early childhood. Bracing for moderate curves. Spinal fusion surgery for severe or progressive curves affecting pulmonary function.

Diagnosis at KIMS

Diagnosis and Assessment at KIMS

Familial dysautonomia is diagnosed and assessed at KIMS through a structured four-stage workflow that begins with the five clinical criteria (absent fungiform papillae, absent histamine flare, absent deep tendon reflexes, methacholine miosis, Ashkenazi ancestry) confirmed by IKBKAP genetic testing, expands to autonomic function testing with 24-hour BP monitoring, thermoregulation, and Schirmer testing, evaluates pulmonary function and aspiration risk with HRCT, swallow assessment, and polysomnography, and characterises the nutritional status with gastrostomy planning :

1

Clinical diagnosis — the five criteria

Criteria for FD diagnosis (all must be present): (1) Absent fungiform papillae · (2) Absent flare response to intradermal histamine (0.1 mg/0.1 mL in volar forearm — no surrounding erythematous flare) · (3) Absent deep tendon reflexes · (4) Miosis with methacholine (pupillary constriction with dilute methacholine due to denervation supersensitivity) · (5) Ashkenazi Jewish ancestry. IKBKAP genetic testing confirms the diagnosis.

2

Autonomic function testing

Cardiovascular autonomic testing (as per dysautonomia page) · 24-hour BP monitoring (supine hypertension + orthostatic hypotension pattern) · Temperature regulation testing (thermoregulatory sweat test: impaired or absent) · Ophthalmology (Schirmer test for alacrima: reduced tear production).

3

Pulmonary function and aspiration assessment

Pulmonary function tests · HRCT chest (for aspiration lung disease: lower lobe bronchiectasis) · Modified barium swallow / videofluoroscopy for aspiration risk assessment · Polysomnography (for periodic breathing and sleep-disordered breathing from abnormal ventilatory drive).

4

Gastrostomy and nutritional management

Oropharyngeal dysphagia + chronic aspiration + vomiting crises = severe nutritional risk. Gastrostomy (PEG or G-tube) is recommended when: recurrent aspiration pneumonia · Weight loss despite oral intake · Vomiting crises causing dehydration and electrolyte disturbance. Nutritional support via gastrostomy dramatically reduces aspiration pneumonia frequency and improves growth.

Related Conditions

Familial dysautonomia belongs to the family of autonomic nervous system disorders evaluated and managed at KIMS Neuroscience. Explore related conditions.

FAQs

Frequently Asked Questions

A smooth tongue with no bumps. No tears when crying. A blood pressure that swings dangerously during stress. Familial dysautonomia is rare but it has a specific diagnosis, a specific community, and a structured multidisciplinary care plan.

At KIMS Hyderabad, the clinical genetics and autonomic neurology teams provide the full FD evaluation and ongoing management. Call 040-44885000.

040-44885000

International enquiries: info@kimsneurosciences.com